Investors – The Share

Dividend policy

Cinclus Pharma is in a phase that requires funding of pre-clinical and clinical development of its drug candidate to be prioritized. Cinclus Pharma has not paid any dividend in the past and does not intend to pay any dividend in the coming years. Any future dividend and the amount thereof will be determined based on Cinclus Pharma’s growth, earnings development, and the Company’s general capital requirements. The board of directors is of the opinion that the financial resources should be used for the development of its drug candidate. In light of the Company’s financial position and negative results, the board of directors does not intend to propose any dividend to be distributed until Cinclus Pharma generates long-term sustainable earnings and has a positive cash flow. To the extent that dividends are proposed, they shall be appropriate to the objectives, scale and risk of the business of the Company.